Jaka jest cena za HLS Therapeutics Inc. (HLS)

Cena za HLS Therapeutics Inc. (HLS) wynosi $2.75

Jaka jest kapitalizacja rynkowa dla HLS Therapeutics Inc. (HLS)

Kapitalizacja rynkowa dla HLS Therapeutics Inc. (HLS) wynosi $86.08M

HLS Therapeutics Inc. (HLS) Podziały Akcji

HLS Therapeutics Inc. operates as a specialized pharmaceutical firm, concentrating on the acquisition and commercialization of medicinal products, primarily within the niche central nervous system (CNS) and cardiovascular (CV) sectors. Its reach extends across Canada, the United States, and international markets. The company's core product lineup includes Clozaril, an atypical antipsychotic used in the treatment of schizophrenia; Vascepa, an icosapent ethyl capsule formulation; and PERSERIS, an injectable risperidone product for treating schizophrenia. Additionally, HLS offers MyCare psychiatry laboratory assays and MyCare Insite tests for point-of-care therapeutic drug-level monitoring. Furthermore, the company possesses U.S. marketing privileges for Absorica, a commercial-stage dermatology solution, and Canadian rights for Trinomia, a cardiovascular therapeutic. It also manages a portfolio of royalty interests from four distinct healthcare products. Founded in 2018, HLS Therapeutics Inc. is based in Etobicoke, Canada.

Rok	Podział	Mnożnik	Skumulowany mnożnik
Za mało danych dla podanych dat.

Rok

Podział

Mnożnik

Skumulowany mnożnik

Za mało danych dla podanych dat.

Firma	Liczba podziałów akcji	Skumulowany mnożnik	Kraj
MERCK Kommanditgesellschaft auf Aktien MER.SW	0	-	DE
Merck KGaA MRK.DE	0	-	DE
Takeda Pharmaceutical Company Limited 4502.T	0	-	JP
Galderma Group AG GALD.SW	0	-	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	5	x119	IN

Firma

Liczba podziałów akcji

Skumulowany mnożnik

Kraj